The agency plans to launch BALANCE in Medicaid as early as May 2026 and in January 2027 for Part D
Compounded Semaglutide contains the same active ingredient found in Ozempic and Wegovy the GLP-1 receptor agonist proven to reduce appetite, slow digestion, and drive meaningful, sustainable weight loss
It represents a dynamic equilibrium where the amount administered equals the amount eliminated, optimising blood glucose control and appetite regulation whilst minimising adverse effects
Is There a Risk of Yo-Yo Effect
Front Endocrinol (Lausanne) 14(12):735824 Cheng L, Hu Y, Li YY, Cao X, Bai N, Lu TT, Li GQ, Li N, Wang AN, Mao XM (2019) Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
These are all areas impacted by declining estrogen